Skip to main content

Published locations for Reslizumab: FDA panel recommends approval for adults, but not children

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Reslizumab: FDA panel recommends approval for adults, but not children

User login

  • Reset your password
  • /content/reslizumab-fda-panel-recommends-approval-adults-not-children
  • /familypracticenews/article/105071/immunology/reslizumab-fda-panel-recommends-approval-adults-not
  • /internalmedicinenews/article/105071/immunology/reslizumab-fda-panel-recommends-approval-adults-not
  • /pediatricnews/article/105071/immunology/reslizumab-fda-panel-recommends-approval-adults-not-children
  • /pulmonary-health-hub/article/105071/immunology/reslizumab-fda-panel-recommends-approval-adults-not
  • /pediatrics/article/105071/immunology/reslizumab-fda-panel-recommends-approval-adults-not-children
  • /internalmedicine/article/105071/immunology/reslizumab-fda-panel-recommends-approval-adults-not
  • /familymedicine/article/105071/immunology/reslizumab-fda-panel-recommends-approval-adults-not
  • /chestphysician/article/105071/immunology/reslizumab-fda-panel-recommends-approval-adults-not